Curenetics Joins Forces with Queen Mary University London and Oracle Cancer Trust

Curenetics Joins Forces with Queen Mary University London & Oracle Cancer Trust in Revolutionary AI-Enabled Oral Cancer Test- qMIDS Supported by NIHR

Curenetics, Queen Mary University London (QMUL),  Oracle Cancer Trust and South East Health Technologies Alliance (SEHTA) are working collaboratively to pioneer a transformative approach to oral cancer detection through the Novel AI-Enabled qMIDS Test. The research is funded by the National Institute for Health and Care Research (NIHR), the research partner of the NHS, public health and social care. This groundbreaking project is poised to elevate precision cancer diagnostics by harnessing the power of artificial intelligence.

The Novel AI-Enhanced qMIDS Test, an innovative fusion of state-of-the-art technologies, presents a revolutionary solution to the challenge of oral cancer diagnosis. By integrating AI with the quantitative Malignancy Index Diagnostic System (qMIDS), rapid and accurate oral cancer detection is now possible even in the presence of seemingly inconspicuous mouth lesions. The test employs reverse transcription quantitative PCR to analyze the expression levels of 16 genes (mRNA) within a minimally invasive 1-mm3 tissue biopsy. These gene expression profiles are then translated into a clinically meaningful quantitative malignancy index through an AI-powered algorithm, enabling precise stratification of cancer risk.

This cutting-edge research initiative represents a collaboration between the fields of oral cancer medicine, cancer biology and artificial intelligence. The research team is led by Dr. Sola Adeleke, Dr. Muy-Teck Teh, Dr. Barbara Carey, Gemma McKnight, and experts from SEHTA. Together they bring a wealth of expertise and a shared dedication to pushing the boundaries of cancer diagnostics.

Future Implications

Dr. Sola Adeleke, Founder of Curenetics, expressed the immense significance of this partnership: “Our collaboration with Queen Mary University London and Oracle Cancer Trust, under the auspices of NIHR, marks a giant stride in validating the Novel AI-Enhanced qMIDS Test. This research holds the potential to revolutionize the way we approach cancer diagnosis, offering an unprecedented level of accuracy and speed that has the potential to redefine patient care.”

The Novel AI-Enhanced qMIDS Test stands as a testament to the relentless pursuit of innovation in healthcare. By combining the expertise of multiple leading institutions, this research initiative underscores the commitment of all parties involved to transform the landscape of oral cancer detection and management.

As the research continues to progress, the collaborative efforts of Curenetics, Queen Mary University London, Oracle Cancer Trust, SEHTA and NIHR stand poised to redefine the future of oral cancer diagnostics, exemplifying the profound impact that can be achieved through the integration of AI and cancer medicine.

Charity Administrator Job – We’re recruiting

We are looking for a dedicated Administrator to join our team.

Oracle´s Golf Day 2025 – Sonning GC, Reading

Oracle´s annual golf day is on 13th June 2025 at Sonning Golf Club, Reading.

Oracle´s annual Oncology meeting

meeting to discuss cutting edge advancements in the treatment of head and neck cancer

Magical Christmas Concert at the enchanting Lumley Castle

Oracle proudly presents a Magical Christmas Concert at the enchanting Lumley Castle on 30th November 2024

Cancer Treatment Wait Times risking lives

Patients face long delays, only 50% seen within the NHS target of 62 days.

Jamie Theakston announces Laryngeal cancer diagnosis

Jamie has had a lesion removed from his vocal chords (Larynx)

Make Sense Campaign 2024

Oracle Head & Neck Cancer UK Supports Make Sense Campaign 2024 Raising Awareness for Head and Neck Cancer We are proud to support the Make Sense Campaign (16th – 21st…

News coverage heralds the start of annual HPV vaccinations

Another busy week for Oracle HNCUK promoting the start of the annual autumn HPV vaccination programme for year 8 children in UK high schools.

Annual Winter Glory Concert, Nov 21st 2024

Join us for an evening of uplifting classical music and a chance to reconnect with fellow supporters.

Mouth Cancer Awareness – NHS England and Asda Team Up

New look mouthwash and toothpaste products encourage shoppers to be body aware and contact their GP or dental practice.

Cancer Support Group 6 Year Anniversary

“We could never have imagined just how amazing it would be and just how supportive you would all be to each other”

World Head & Neck Cancer Awareness day 2024

World Head & Neck Cancer Awareness day 2024 presentation at Merck & Co to promote #HeadNeckCheck

Respiratory-Swallow Training in Head and Neck Cancer

New training, which aims to change the breathing-swallowing pattern of patients with swallowing difficulties, has been developed in America.

EasyJet Boarding Pass – Check in and check out information on head & neck cancers.

An estimated 40,000 passengers are being told to ‘Silence the threat. Give it the check’ in the our latest campaign.

Help Beat Head and Neck Cancer